Showing results (1181-1190 of 1,612) with videos related to

Sort By:
Pageof 162
Cardiovascular Research|May 22, 2003
The human adult cardiomyocyte phenotypeS D Bird, P A Doevendans, M A van Rooijen, et al.
Stem Cells International|September 14, 2011
Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ miceBarbara Ghinassi, Leda Ferro, Francesca Masiello, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 1, 1993
Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in FranceJ H Jacob, A Riviere, A M Mandard, et al.
Cost Effectiveness and Resource Allocation : C/E|September 6, 2013
A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countriesSebastián García Martí, Lisandro Colantonio, Ariel Bardach, et al.
Medicine|November 15, 2014
Sex differences in patients receiving anticoagulant therapy for venous thromboembolismAngeles Blanco-Molina, Iolanda Enea, Telma Gadelha, et al.
Prostate Cancer and Prostatic Diseases|April 17, 2019
Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapyRishi Deka, Daniel R Simpson, Matthew S Panizzon, et al.
Human Molecular Genetics|July 20, 2012
Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouseGaynor Miller, Chris J Moore, Rebecca Terry, et al.
Ebiomedicine|October 17, 2025
A Delphi study on valuing DNA sequencing in oncology: a European stakeholder developed framework for assessing next generation sequencing and comprehensive genomic profiling diagnosticsAugustovski Federico, Chavez Danitza, Haig Madeleine, et al.
Blood Cancer Journal|December 20, 2024
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance studyMajid Jaberi-Douraki, Xuan Xu, Danai Dima, et al.
World Neurosurgery|August 2, 2024
Neurosurgical Implications of Targeting Hypoxia-Inducible Factor 2α in Hemangioblastomas with BelzutifanAndrew D Pumford, Megan Bauman, Samantha Bouchal, et al.
Pageof 162